Agree, Viper, but the market no longer has any faith that management can finish a trial after pulling the plug on two probably successful trials. IMO the Sanford trial for T1D is their last shot at credibility.
I wonder what's the sense of being so optimistic. With the stock price that sits where it is, with around 7 to 8M of cash burn per quarter, and so on, please tell me where you find such optimism. Seriously.